Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Rades

Showing results (321-330 of 586) with videos related to

Pageof 59
Sort By:
Anticancer Research|June 11, 2013
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancerStefan Reers, Ann-Christin Pfannerstill, Dirk Rades, et al.
Anticancer Research|January 25, 2023
Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and NeckInga Zwaan, Tamer Soror, Karl L Bruchhage, et al.
In Vivo (Athens, Greece)|October 24, 2018
Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal CancerMaxi Treder, Rasmus Peuliche Vogelsang, Stefan Janssen, et al.
Radiology and Oncology|September 29, 2016
Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myelomaDirk Rades, Antonio J Conde-Moreno, Jon Cacicedo, et al.
Clinics and Practice|August 27, 2025
Assessment of Physical Activity During Chemotherapy and/or Immunotherapy for Non-Small Cell Lung Cancer (NSCLC): Protocol of the APACHIE-01 StudyDirk Rades, Laura Doehring, Christian Staackmann, et al.
Anticancer Research|May 7, 2017
Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal CancerDirk Rades, Annett Maderer, Annika Panzner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2009
Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neckSilke Tribius, Stefanie Kronemann, Yasemin Kilic, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2011
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN)Dirk Rades, Nina D Seibold, Maximilian P Gebhard, et al.
Clinical Neurology and Neurosurgery|June 19, 2012
Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resectionDuong Anh Vuong, Dirk Rades, Albertus T C van Eck, et al.
Cancers|September 13, 2025
Peritumoral Invasion and Survival in Patients with Oral Squamous Cell Carcinoma-The Role of Perineural and Lymphovascular InvasionSamer George Hakim, Ubai Alsharif, Mohamed Falougy, et al.
Pageof 59

Showing results (321-330 of 586) with videos related to

Sort By:
Pageof 59
Anticancer Research|June 11, 2013
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancerStefan Reers, Ann-Christin Pfannerstill, Dirk Rades, et al.
Anticancer Research|January 25, 2023
Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and NeckInga Zwaan, Tamer Soror, Karl L Bruchhage, et al.
In Vivo (Athens, Greece)|October 24, 2018
Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal CancerMaxi Treder, Rasmus Peuliche Vogelsang, Stefan Janssen, et al.
Radiology and Oncology|September 29, 2016
Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myelomaDirk Rades, Antonio J Conde-Moreno, Jon Cacicedo, et al.
Clinics and Practice|August 27, 2025
Assessment of Physical Activity During Chemotherapy and/or Immunotherapy for Non-Small Cell Lung Cancer (NSCLC): Protocol of the APACHIE-01 StudyDirk Rades, Laura Doehring, Christian Staackmann, et al.
Anticancer Research|May 7, 2017
Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal CancerDirk Rades, Annett Maderer, Annika Panzner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2009
Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neckSilke Tribius, Stefanie Kronemann, Yasemin Kilic, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2011
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN)Dirk Rades, Nina D Seibold, Maximilian P Gebhard, et al.
Clinical Neurology and Neurosurgery|June 19, 2012
Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resectionDuong Anh Vuong, Dirk Rades, Albertus T C van Eck, et al.
Cancers|September 13, 2025
Peritumoral Invasion and Survival in Patients with Oral Squamous Cell Carcinoma-The Role of Perineural and Lymphovascular InvasionSamer George Hakim, Ubai Alsharif, Mohamed Falougy, et al.
Pageof 59